Kriya Therapeutics
Palo Alto, California, United StatesFounded 2019203+ employeesPrivate
$921.3M raisedGrowth· last: series d (Aug 2025)· 6 rounds
Backed by(18 investors)
Patient Square Capital · LeadPremji Invest · LeadQVT Financial · LeadTranshuman Capital · Lead+8 more
Our mission is to revolutionize medicine, with the ultimate goal of eliminating human suffering and enabling people to live without the burden of disease. Kriya is a biopharmaceutical company developing gene therapies to address chronic diseases affecting millions of people around the world. With operations in Research Triangle Park, North Carolina, and Palo Alto, California, Kriya has raised over $600 million to advance a broad pipeline of gene therapies in ophthalmology, metabolic disease and neurology. For more information, please visit www.kriyatx.com and follow us on LinkedIn and X (Formerly Twitter).
